A new method of urine test analysis is allowing researchers to determine what street drugs are emerging in B.C., at a far faster rate than existing approaches.
In on Wednesday (Nov. 15), a team of experts showed how they were able to use thousands of existing B.C. urine samples and compare them against drug findings elsewhere in the world to tentatively identify what new substances are circulating in the community.
BԪַThe earlier we can detect these drugs, the sooner community-based drug alerts can be issued and staff at Overdose Prevention Services can prepare treatment options,BԪַ said Aaron Shapiro, an associate scientific director at the B.C. Provincial Toxicology Centre and one of the studyBԪַs authors, in an email to Black Press Media.
The drugs they are concerned with identifying are known as BԪַnovel psychoactive substancesBԪַ or BԪַdesigner drugs,BԪַ and are derivatives of known substances, often cooked up black-market chemists. When they arrive on the street, the drugsBԪַ potencies and effects arenBԪַt always known to those using them and they can increase the risk of overdose or death. Those treating someone for an overdose involving a designer drug also may not know the best way to respond, if they have never seen the substance or symptoms before.
READ ALSO:
The studyBԪַs lead author, Michael Skinnider, said this is a serious problem as dozens to hundreds of designer drugs emerge on the market every year. In order for laboratories to test for each substance, they would have to obtain a reference sample of every new drug. Those can be costly, however, and, even if a lab could afford them all, Skinnider said the sheer volume of possible drugs would make it highly impractical.
BԪַSo in practice, labs have to make kind of educated guesses about which drugs they should be developing these clinical grade tests for,BԪַ Skinnider said.
The goal of their study was to make that process more efficient. By analyzing findings from laboratories around the world, the team of researchers was able to develop a database of the chemical components that make up 83 emerging designer drugs. It then compared those components with the results of more than 12,000 urine tests taken between August 2019 and August 2022 at the B.C. Provincial Toxicology Centre to determine if any of the designer drugs had likely been present.
Skinnider said this approach doesnBԪַt identify drugs with 100 per cent certainty, but it does better indicate to labs which drug tests they should prioritize developing next.
BԪַUltimately, the hope would be that this could dramatically reduce the lag between the introduction of a drug into the community and the labBԪַs ability to test for that drug with clinical samples.BԪַ
In their analysis, Skinnider and his team tentatively identified 31 of the possible 83 designer drugs in the B.C. urine samples. Ten of those drugs showed up in at least 20 samples each. The most commonly detected drug was fluorofentanyl, an analog of fentanyl, which showed up in 301 samples.
Skinnider said this gives labs solid data to go off of when they decide which reference drugs to purchase and develop clinical tests for. Already, the B.C. Centre for Disease Control is working to implement the new designer drug database into its clinical drug screening process.
Skinnider said theyBԪַre also looking at combining the database with an artificial intelligence platform he helped develop a couple of years ago that can predict what designer drugs may be emerging before they actually appear.
READ ALSO: